Navigation Links
FRC: NIH Stem Cell Guidelines Reflect Poor Science, Ignore Real Hope for Patients
Date:4/17/2009

WASHINGTON, April 17 /PRNewswire-USNewswire/ -- Today, Family Research Council President Tony Perkins responded to the National Institutes of Health (NIH) issued draft guidance for implementing President Obama's executive order to fund embryonic stem cell research (ESCR). President Obama's decision and these guidelines will remove key limits on federal funding of ESCR. Following is Perkins' statement:

(Logo: http://www.newscom.com/cgi-bin/prnh/20080930/FRCLOGO )

"The research that President Obama supports is not sound science and will destroy human life. And now the NIH draft guidelines demanded by the President will do nothing to advance stem cell research that is showing near-term benefit for suffering patients. Instead, the guidelines implement a plan that will force taxpayers to foot the bill for research that involves human embryo destruction.

"The NIH guidelines will create an incentive to cannibalize the so-called 'leftover embryos,' though they will not fund research on stem cells derived from cloning, parthenogenesis and human-animal hybrids. However, NIH clearly believes the President's executive order allows them to fund such unethical research at any point in the future. The guidelines purport to have tight informed consent requirements, but they don't even require IVF doctors and the stem cell researchers to work separately, thereby opening a gaping loophole for the researchers to increase embryo production for their research.

"Instead of funding more embryo destructive research, the government should fund research using adult stem cells that are on the cutting edge of treating patients for diabetes, spinal cord injury, heart disease, and various cancers. Unfortunately, this draft guidance only diverts limited federal resources to unethical stem cell research that has not successfully treated a single person for any disease.

"Taxpayer funding should instead focus on common ground stem cell research and support legislation like the Patient's First Act sponsored by Rep. Randy Forbes (R-VA) and Rep. Dan Lipinksi (D-IL). Congress also needs to renew the Dickey-Wicker Amendment, which would forbid taxpayer funding of the creation of human embryos solely for their destruction.

"There is great potential in this country for research and procedures that will cure many diseases and allow us to maintain our ethical standards. I urge Members of Congress to support Dickey-Wicker and focus funding on the proven science of adult stem cells."


'/>"/>
SOURCE Family Research Council
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. International Guidelines for First-Line use of Freelite(TM) in Diagnosis and Management of Multiple Myeloma to be Published in "Leukemia"
2. The International Society for Stem Cell Research Releases New Guidelines to Shape Future of Stem Cell Therapy
3. British School Kids With Diabetes Gain First Time Freedom From Injections With New Insulin Pump Guidelines
4. Expert Consensus Panel Recommendation for Incorporating Lp-PLA2 Testing into Cardiovascular Disease Risk Assessment Guidelines
5. Pharmaceutical Competitive Intelligence Excellence: Optimizing Data Collection with Approved Guidelines
6. Fungitell(R) CE Marked, Referenced in IDSA and NCCN Guidelines and Added to EORTC-MSG Revised Definitions of Invasive Fungal Disease
7. American Urological Association (AUA) Clinical Guidelines Recognizes Cryotherapy as Treatment Option for Prostate Cancer Patients
8. Atherotech VAP Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients
9. Biopure Operations Compliant With U.K. Manufacturing Guidelines
10. Long-awaited international ethical guidelines for biobank researchers
11. Updated NIH Guidelines Offer Valuable Information on Asthma Diagnosis and Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity ... intelligent tools designed, tuned and optimized exclusively for Okuma CNC machining centers at ... result of a collaboration among several companies with expertise in toolholding, cutting tools, ...
(Date:6/22/2016)... 22, 2016 Research and Markets has announced ... report to their offering. ... from $29.3 billion in 2013. The market is expected to grow ... 2015 to 2020, increasing from $50.6 billion in 2015 to $96.6 ... during the forecast period (2015 to 2020) are discussed. As well, ...
(Date:6/22/2016)... , June 22, 2016   ViaCyte, Inc. , ... stem cell-derived islet replacement therapy for the treatment of ... ISSCR 2016 Annual Meeting.  ISSCR 2016, the Global Stem ... at Moscone West in San Francisco.  ... presentations are as follows:Event: , Focus Session: Tools for ...
Breaking Biology Technology:
(Date:6/2/2016)... NEW YORK , June 2, 2016   The ... (Weather), is announcing Watson Ads, an industry-first capability in which ... advertising, by being able to ask questions via voice or ... Marketers have long ... with the consumer, that can be personal, relevant and valuable; ...
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a provider ... MegaMatcher Automated Biometric Identification System (ABIS) , ... multi-biometric projects. MegaMatcher ABIS can process multiple complex ... any combination of fingerprint, face or iris biometrics. ... SDK and MegaMatcher Accelerator , which ...
Breaking Biology News(10 mins):